ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 18, 2020
ProQR to Present at the RBC Capital Markets Healthcare Conference Press release … amaurosis 10, Usher syndrome type 2 and autosomal dominant retinitis pigmentosa. Based on our unique proprietary RNA … May 15, 2019
ProQR to Present at the H.C. Wainwright Global Life Sciences Conference Press release … amaurosis 10, Usher syndrome type 2 and autosomal dominant retinitis pigmentosa. Based on our unique proprietary RNA … April 01, 2019
ProQR Announces Upcoming Investor Conferences in November and December Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 08, 2021
ProQR to Present at Upcoming JMP Securities Life Sciences Conference Press release … such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on our unique proprietary RNA … June 10, 2021
ProQR to Present at Cowen and Company 40th Annual Health Care Conference Press release … amaurosis 10, Usher syndrome and autosomal dominant retinitis pigmentosa. Based on our unique proprietary RNA … February 24, 2020
ProQR to Present at Upcoming Investor Conferences Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. November 13, 2019
ProQR to Present at the JMP Securities Life Sciences Conference Press release … amaurosis 10, Usher syndrome type 2 and autosomal dominant retinitis pigmentosa. Based on our unique proprietary RNA … June 03, 2019
ProQR Announces Upcoming Investor Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 03, 2021
ProQR to Participate in Upcoming Investor Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 03, 2020